Andrew Tonkin Selected Research

Rivaroxaban

8/2021	Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
1/2019	Stroke Outcomes in the COMPASS Trial.
1/2019	Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective.
11/2018	Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Tonkin Research Topics

Disease

25	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2003
18	Heart Failure 12/2022 - 10/2003
17	Coronary Disease (Coronary Heart Disease) 01/2021 - 03/2002
14	Myocardial Infarction 07/2019 - 03/2002
9	Hypertension (High Blood Pressure) 10/2022 - 11/2006
8	Neoplasms (Cancer) 09/2023 - 05/2002
8	Stroke (Strokes) 01/2019 - 04/2003
7	Unstable Angina 12/2017 - 03/2002
5	Acute Coronary Syndrome 12/2017 - 07/2005
4	Dementia (Dementias) 09/2023 - 01/2018
4	Chronic Renal Insufficiency 09/2011 - 09/2004
3	Thrombosis (Thrombus) 11/2023 - 03/2012
3	Hemorrhage 11/2023 - 08/2021
3	Atherosclerosis 01/2023 - 01/2019
3	Knee Osteoarthritis 01/2022 - 12/2015
3	Peripheral Arterial Disease 08/2021 - 01/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 08/2021 - 02/2007
3	Vascular Diseases (Vascular Disease) 11/2018 - 12/2002
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2007
2	Dyslipidemias (Dyslipidemia) 10/2022 - 01/2014
2	Pain (Aches) 11/2021 - 11/2006
2	Obesity 01/2020 - 11/2006
2	Ischemic Stroke 07/2016 - 01/2004
2	Frailty 07/2014 - 01/2008
2	Cognitive Dysfunction 02/2012 - 01/2003
2	Systolic Heart Failure 09/2011 - 02/2007
1	Necrosis 08/2023
1	Sepsis (Septicemia) 01/2023
1	Infections 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 12/2022
1	Chronic Pain 12/2022
1	Myalgia 01/2022
1	Osteoarthritis 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Carotid Artery Diseases 01/2019
1	Morbid Obesity 01/2019
1	Diabetes Mellitus 12/2017
1	Atherosclerotic Plaque (Atheroma) 07/2016
1	Inflammation (Inflammations) 12/2015

Drug/Important Bio-Agent (IBA)

17	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2023 - 01/2004
16	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 01/2003
16	Pravastatin (Pravachol)FDA LinkGeneric 02/2014 - 03/2002
14	LipidsIBA 10/2022 - 03/2002
13	CholesterolIBA 08/2023 - 03/2002
8	LDL CholesterolIBA 10/2022 - 05/2004
4	C-Reactive ProteinIBA 08/2023 - 02/2007
4	oxidized low density lipoproteinIBA 10/2022 - 05/2004
4	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2016
4	RivaroxabanIBA 08/2021 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2018
3	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2023 - 02/2007
3	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2003
3	HDL CholesterolIBA 10/2022 - 05/2004
3	omega-Chloroacetophenone (Mace)IBA 08/2021 - 01/2018
2	Endothelin-1 (Endothelin 1)IBA 08/2023 - 02/2007
2	Interleukin-6 (Interleukin 6)IBA 08/2023 - 02/2007
2	Proprotein Convertase 9IBA 01/2023 - 01/2021
2	Atorvastatin (Lipitor)FDA Link 01/2022 - 11/2021
2	CreatinineIBA 01/2022 - 09/2004
2	fibrin fragment D (D-dimer)IBA 01/2019 - 12/2017
2	Troponin IIBA 12/2017 - 02/2014
2	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 12/2015 - 09/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2015 - 09/2011
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 11/2023
1	Lipoprotein(a)IBA 11/2023
1	pro-brain natriuretic peptide (1-76)IBA 08/2023
1	TroponinIBA 08/2023
1	SelectinsIBA 08/2023
1	Cell Adhesion MoleculesIBA 08/2023
1	E-SelectinIBA 08/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2023
1	alirocumabIBA 01/2023
1	evolocumabIBA 01/2023
1	ALN-PCSIBA 01/2023
1	PCSK9 InhibitorsIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 12/2022
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2021
1	dapagliflozinIBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	CalciumIBA 01/2021
1	canakinumab FDA Link 01/2019
1	Cystatin CIBA 12/2017
1	Simvastatin (Zocor)FDA LinkGeneric 12/2016
1	Ezetimibe (Zetia)FDA Link 12/2016
1	AntibodiesIBA 07/2016
1	Polysaccharides (Glycans)IBA 07/2016
1	A 17 (A-17)IBA 07/2016
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 07/2016

Therapy/Procedure

18	Therapeutics 01/2021 - 01/2003
6	Secondary Prevention 01/2019 - 01/2004
4	Polypharmacy 01/2020 - 07/2005
2	Percutaneous Coronary Intervention 07/2019 - 01/2018
1	Pain Management 01/2020
1	Patient Readmission 12/2015